The Danish medtech company RSP Systems has secured nearly DKK 50 million through fundraising. However, the goal is to raise three times as much in order to launch a non-invasive blood glucose meter in Europe by the beginning of 2020, according to the company's CSO and former CEO.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.